A-Labs Capital II Corp
A-Labs Capital II Corp. does not have significant operations. It intends to identify and evaluate assets or businesses with a view to complete a qualifying transaction in the software, hardware, and biotech sectors. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.
A-Labs Capital II Corp (ALAB-P) - Total Liabilities
Latest total liabilities as of September 2025: CA$196.61K CAD
Based on the latest financial reports, A-Labs Capital II Corp (ALAB-P) has total liabilities worth CA$196.61K CAD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
A-Labs Capital II Corp - Total Liabilities Trend (2018–2024)
This chart illustrates how A-Labs Capital II Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
A-Labs Capital II Corp Competitors by Total Liabilities
The table below lists competitors of A-Labs Capital II Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GENESIS MIN
BE:3G2
|
Germany | €217.65 Million |
|
WEATHERF INT REG.
F:WH4
|
Germany | €1.17 Million |
|
TEKMIRA PHARM
BE:I9DN
|
Germany | €33.55 Million |
|
Assetco Plc
LSE:ASTO
|
UK | GBX7.40 Million |
|
OMNIA HOLD
BE:OHZ
|
Germany | €8.43 Billion |
Liability Composition Analysis (2018–2024)
This chart breaks down A-Labs Capital II Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2234.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how A-Labs Capital II Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for A-Labs Capital II Corp (2018–2024)
The table below shows the annual total liabilities of A-Labs Capital II Corp from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CA$189.76K | +5.55% |
| 2023-12-31 | CA$179.78K | +8.23% |
| 2022-12-31 | CA$166.11K | +367.51% |
| 2021-12-31 | CA$35.53K | +25.12% |
| 2020-12-31 | CA$28.40K | +13.31% |
| 2019-12-31 | CA$25.06K | +51.68% |
| 2018-12-31 | CA$16.52K | -- |